Jimmy D. Bartlett, O.D. – Department Chair

Jimmy D. Bartlett, O.D., D.O.S., Sc.D.
Professor, Optometry
Department Chair

Contact Information:
Academic Office - (205) 934-3036
Patient Services/Appointments:
UOG Faculty Practice - (205) 934-5161

Physical Address:
522 Henry Peters Building
1716 University Boulevard

Mailing Address:
HPB 522
1530 Third Avenue South
Birmingham, AL 35294-0010

Biographical Sketch:

Education:
1972, B.S., Southern College of Optometry, Memphis, Tennessee
1974, O.D., Southern College of Optometry, Memphis, Tennessee
1986, D.O.S. (Honoris causa), Southern College of Optometry, Memphis, Tennessee
2002, Sc.D. (Honoris causa), State University of New York, New York City

Administrative Responsibilities:

Chairman, Department of Optometry
Director of the Professional Program in Optometry

Secondary Appointments:

Professor, Department of Pharmacology and Toxicology, School of Medicine

Scholarly Activity:

Research:
Special clinical and research interests lie in ocular pharmacology and investigational drugs, with emphasis in external eye disease and glaucoma. 

Recent Publications:

Semes L, Shaikh A, McGwin G, Bartlett JD. The relationship among  race, iris color, central corneal thickness, and intraocular pressure. Optom Vis Sci 2006; 83: 512-515

Holland EJ, Bartlett JD, Paterno MR, et.al. Effects of loteprednol/tobramycin versus dexamethasone/tobramycin on intraocular pressure in healthy volunteers. Cornea 2008; 27:50-55.

Evans DW, Bartlett JD, Houde B, et.al. Latanoprost-induced stablization of central visual function in patients with primary open-angle glaucoma. J Ocul Pharmacol Ther 2008; 24:224-229.

Bartlett JD, Jaanus SD, eds. Clinical ocular pharmacology, 5th ed., St. Louis: Elsevier, 2008.

Coulter RA, Bartlett JD, Fiscella RG. Pharmacotherapy of the ophthalmic patient. In: Bartlett JD, Jaanus SD, eds. Clinical ocular pharmacology, 5th ed., St. Louis: Elsevier, 2008:3-15.

Bartlett JD. Ophthalmic drug delivery. In: Bartlett JD, Jaanus SD, eds. Clinical ocular pharmacology, 5th ed., St. Louis: Elsevier, 2008:39-52.

Than TP, Bartlett JD.  Local anesthetics. In: Bartlett JD, Jaanus SD, eds. Clinical ocular pharmacology, 5th ed., St. Louis: Elsevier, 2008:85-95.

Bartlett JD, Holdeman NR. Analgesics for treatment of acute ocular pain. In: Bartlett JD, Jaanus SD, eds. Clinical ocular pharmacology, 5th ed., St. Louis: Elsevier, 2008:97-111.

Bartlett JD, Fiscella RG, Jaanus SD, Barnebey H. Ocular hypotensive drugs. In: Bartlett JD, Jaanus SD, eds. Clinical ocular pharmacology, 5th ed., St. Louis: Elsevier, 2008:139-174.

Prokopich CL, Bartlett JD, Jaanus SD. Ocular adverse drug reactions to systemic medications. In: Bartlett JD, Jaanus SD, eds. Clinical ocular pharmacology, 5th ed., St. Louis: Elsevier, 2008:701-759.

Bartlett JD, Holland EJ, Usner D, et.al. Tolerability of loteprednol/tobramycin vs dexamathasone/tobramycin in healthy volunteers:  Results of a four-week, randomized, double-masked, parallel-group study. Curr Med Res Opin 2008; 24:2219-2227.

Bartlett JD, Karpecki PM, Melton R, Thomas RK. Diagnostic and treatment algorithms for ocular surface disease states - allergy. Rev Optom 2008; 145:S1-S12.

Bartlett JD, Fiscella RG, Bennett E, et.al., eds. Ophthalmic drug facts, 21^st ed., St. Louis:  Wolters Kluwer Health, 2010.